CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation-Reference-Cited by-同舟云学术

CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation

Published:2002-04 Issue:8 Volume:73 Page:1339-1341
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Krasinskas Alyssa M.,Kreisel Daniel,Acker Michael A.,Bavaria Joseph E.,Pochettino Alberto,Kotloff Robert M.,Arcasoy Selim,Blumenthal Nancy,Kamoun Malek,Moore Jonni S.,Rosengard Bruce R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference10 articles.

1. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation

2. Antilymphocyte-antibody prophylaxis: Review of the adult experience in heart transplantation

3. Cytolytic Induction Therapy in Heart and Lung Transplantation: The Protagonist Opinion

4. RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORING

5. EFFECT OF IMMUNOSUPPRESSIVE THERAPY FOR RENAL ALLOGRAFTS ON THE NUMBER OF CIRCULATING SHEEP RED BLOOD CELL ROSETTING CELLS

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rejection in Liver Transplantation Recipients;Journal of Clinical and Experimental Hepatology;2024-07

2. Immune cell function assay and T lymphocyte counts lack association with rejection or infection in pediatric heart transplant recipients;Clinical Transplantation;2022-11-27

3. The impact of induction therapy on mortality and treated rejection in cardiac transplantation: A retrospective study;The Journal of Heart and Lung Transplantation;2022-04

4. Drug-Induced Myelosuppression in Kidney Transplant Patients;Experimental and Clinical Transplantation;2021-10

5. Malignancy among adult heart transplant recipients following patient‐tailored dosing of anti‐thymocyte globulin: a retrospective, nested case‐control study of individualized dosing;Transplant International;2021-09-23